Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
39.04
+0.35 (0.90%)
At close: Sep 26, 2025, 4:00 PM EDT
39.05
+0.01 (0.03%)
After-hours: Sep 26, 2025, 6:55 PM EDT
Exelixis Market Cap
Exelixis has a market cap or net worth of $10.51 billion as of September 26, 2025. Its market cap has increased by 38.35% in one year.
Market Cap
10.51B
Enterprise Value
9.30B
1-Year Change
38.35%
Ranking
Category
Stock Price
$39.04
Market Cap Chart
Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $10.51B, an increase of 1,566.09%. That is a compound annual growth rate of 11.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 10.51B | 10.51% |
Dec 31, 2024 | 9.51B | 27.47% |
Dec 29, 2023 | 7.46B | 44.19% |
Dec 30, 2022 | 5.17B | -10.54% |
Dec 31, 2021 | 5.78B | -7.11% |
Dec 31, 2020 | 6.23B | 16.30% |
Dec 31, 2019 | 5.35B | -8.96% |
Dec 31, 2018 | 5.88B | -34.61% |
Dec 29, 2017 | 8.99B | 110.58% |
Dec 30, 2016 | 4.27B | 233.29% |
Dec 31, 2015 | 1.28B | 355.89% |
Dec 31, 2014 | 281.10M | -75.11% |
Dec 31, 2013 | 1.13B | 34.59% |
Dec 31, 2012 | 839.00M | 36.62% |
Dec 30, 2011 | 614.10M | -31.37% |
Dec 31, 2010 | 894.80M | 13.07% |
Dec 31, 2009 | 791.40M | 49.29% |
Dec 31, 2008 | 530.10M | -41.23% |
Dec 31, 2007 | 902.00M | 4.64% |
Dec 29, 2006 | 862.00M | 10.08% |
Dec 30, 2005 | 783.10M | 10.19% |
Dec 31, 2004 | 710.70M | 41.83% |
Dec 31, 2003 | 501.10M | 9.05% |
Dec 31, 2002 | 459.50M | -44.16% |
Dec 31, 2001 | 822.90M | 25.02% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 650.45B |
Johnson & Johnson | 432.80B |
AbbVie | 389.72B |
UnitedHealth Group | 311.62B |
Novo Nordisk | 242.68B |
Novartis AG | 238.65B |
Abbott Laboratories | 232.44B |
AstraZeneca | 228.75B |